Diacor News and Opinion

A recent commentary has been published in the Journal of the National Cancer Institute, which outlines 10 ways in which a doctor and patient can communicate better, in order for the patient to better understand the treatment risks associated with treating cancer. The commentary gives suggestions such as insisting on plain language, focusing on the absolute risk, and ordering the information in a way in which the patient will best remember it. To view the abstract and purchase the full article, please click here.

September is National Prostate Awareness month, and United States President Barack Obama has issued a statement on the topic. More than 240,000 males will be diagnosed with prostate cancer this year. He encourages all men, particularly those at a higher risk for cancer, to talk with their doctors about how they can reduce their chances of getting prostate cancer. For a link to the statement, please click here.

Researchers from the University of Connecticut and the University of Southern California have submitted a new way to detect ovarian cancer. While the current standard procedure is preemptively removing the ovaries, researchers propose that their new device, which combines photoacoustic imaging, high resolution subsurface imaging, and pulse echo ultrasound can detect ovarian cancer with minimally invasive surgery. The device could be inserted into a small slit in live tissue in order to image patients. For more information, please click here.

Researchers have potentially found a new way of treating glioblastoma, by starving the cancer cells of cholesterol. Glioblastoma is one of the most deadly types of brain cancer, with about 18,000 people a year being diagnosed, and about 13,000 dying from the disease annually. Tumors are extremely hard to remove with surgery, because they invade surrounding brain tissue, and can be resistant to chemotherapy, because some people have genes that cause them to be resistant. For more information on the discovery, please click here.

Diacor will be attending Harvard Medical School's 7th Annual Brachytherapy Review, held at the Hilton Back Bay in Boston, Massachusetts.  The Review is held for radiation oncologists, medical physicists, nurses, and physicians who are interested in brachytherapy. Diacor will have information on the  Zephyr hdr on display, so feel free to stop by and view our product!

 

Researchers have recently published a study in the journal Cancer Cell, which indicates that taking fish oil supplements can decrease the effectiveness of chemotherapy drugs. Researchers found that two fatty acids produced by stem cells in reaction to a commonly used cancer medication, make cancerous cells resistant to treatment. These same fatty acids are found in fish oil supplements, which are commonly taken in addition to cancer treatment. To see the free abstract, or pay for the full article, please click here.

Diacor has recently added LACO as a new distributor for the US Area. LACO has over 65 years of experience selling and servicing radiation therapy centers.  LACO is headquartered in Chesterland, OH.  We look forward to working with Amy Lantz and her team!

For a list of Diacor distributors, please click here.

Our distributor Beijing CAC recently attended the National Advanced Design on Oncology Conference held in Taiyuan China on August 23-27. Below are some photos of the conference. We appreciate all the hard work Beijing CAC has been putting in promoting our products!

 

Diacor will be attending the 53rd Annual Meeting of the American Society for Radiation Oncology (ASTRO), held this year in Miami Florida, October 2-6. More than 11,000 attendees are expected, including oncologists, oncology nurses, radiation therapists, biologists, and other cancer researchers. We will be there displaying both the Zephyr xl and the Zephyr hdr, so please stop by and take a look at our products. We hope to see you there!

For more information about ASTRO, please click here.